(DATS), typical components of garlic, inhibit tumor cell proliferation in culture and chemically induced tumors in experimental animals, such as colon cancer, 25) breast cancer, 26) and lung cancer. 27) Most of these allyl sulfides, which are absorbed in the gastrointestinal tract, are also reported to biotransform to the corresponding allylmercapto glutathione S-conjugate after reacting with endogenous antioxidants, such as cysteine and reduced glutathione (GSH). 28, 29) This allylmercapto glutathione S-conjugate, S-allylmercapto-L-cysteine (SAMC), which is biotransformed from allyl sulfides and from the naturally occurring water-soluble garlic derivatives, also inhibits tumorigenesis. 30) The fact that the chemical instability of these allyl sulfides does not limit their efficacy suggests that SAMC is the main bioactive metabolite. 31) Although not present in raw garlic, SAMC can be found as a stable orally bioavailable organosulfur compound in aged garlic. In addition, SAMC reportedly inhibits growth and induces apoptosis in SW480 and HT 29 human colon cancer cells 32) and prostate cancer cells. 33) Our group also reported that SAMC induces apoptosis in primary gastric cancer cells. 34) SAMC exhibits apoptotic effects through down-regulation of bcl-2/bax proteins and activation of caspase-3 in the gastric cancer cell line.
Despite the abundant in vitro evidence of the effects of garlic-related compounds, the in vivo anticancer effect of SAMC has rarely been reported. This study was designed to investigate the apoptotic effect of SAMC on implanted tumors of human gastric cancer cells in nude mice. Understanding the relationship between apoptosis by SAMC and expression of bcl-2/bax in vivo may allow for its clinical application.
Allylmercapto glutathione S-conjugate, S-allylmercapto-L-cysteine (SAMC), which is biotransformed from allyl sulfides and from naturally occurring water-soluble garlic derivatives, has been known to inhibit tumorigenesis. We found that SAMC was able to induce apoptosis in gastric cancer cells in vitro. We report that SAMC inhibited tumor growth rate by 31.36% and 37.78% at doses of 100 and 300 mg/kg, respectively. Apoptosis in the implanted tumor cells was manifested by apoptotic characteristics, including morphological changes of chromatin crescent, cell shrinkage and membrane blebbing. The apoptosis index of 100 mg/kg and 300 mg/kg of SAMC was 20 Tumor Implantation 5ϫ10 6 cells/0.2 ml/mice of human gastric cancer cells (KMN-45) were injected into subcutaneous tissues of nude mice. The animals commenced treatment on day 2 of control (vehicle, nϭ7), 100 mg/kg (low dose) S-allylmercapto-L-cysteine (nϭ7), and 300 mg/kg (high dose) S-allylmercapto-L-cystein (nϭ7) by daily orogastric feeding and adriamycin (2 mg/kg), a positive control, were daily injected intraperitoneally. Then, changes of tumor volume were measured with Calipus (Mitutoyo Corp., Japan) twice a week, and tumor inhibition rate of each group was calculated according to the following formula.
Where C is control group, T is treated group, V 1 is the volume before treatment (mm 3 ), V 0 is the volume after treated (mm 3 ). This experiment was approved by the ethics committee for animal experiments at Dongseo University. When experimental animals are used, we follow the NIH guidelines for laboratory animals 35) and the Korean revised law for animal protection, 8852. All precautions were taken to care for the animals and to minimize any pain or discomfort.
Tumor Morphology After 24 d of treatment, the mice were euthanized by cervical dislocation and meticulously examined at postmortem. Paraffin-embedded tumor samples were cut into 1 mm sections and attached on glass slides. After deparaffination and dehydration, samples are hematoxylin and eosin (H&E) stained. H&E stained ultrathin sections were observed with a light microscope (BX41TF, Olympus, Japan) with magnification ϫ1000.
Tunel Assay Paraffin-embedded tumor samples were cut into 5 mm sections and attached on silane coated glass slides (MUTO, Japan). Apoptosis in the tumor was measured with In Situ Cell Death Detection kit, POD (Roche, Germany). The tunel assay was carried out following the procedures directions. Tissue sections were deparaffinize in xylene, and hydrated through graded ethanol and then treated with proteinase K (20 mg/ml, Sigma, U.S.A.) for 20 min at RT. And endogenous peroxidase was blocked by 0.3% H 2 O 2 in methanol for 15 min at RT. After the reaction, tissue sections were treated with Tris-HCl with 3% bovine serum albumin for 30 min and then incubated with tunel reaction mixture [containing terminal deoxynucleotidyl transferase from calf thymus (enzyme solution) and nucleotide mixture (label solution)] for 1 h at 37°C in a humidified chamber. Tissue samples were then combined with Converter-POD (containing anti-fluorescein antibody Fab fragments from sheep, conjugated with horse-radish peroxidase), followed by washing and DAB (Sigma, U.S.A.) color reaction. During the tunel procedure samples were washed in phosphate buffered saline (PBS). Tissue sections were counterstained by hematoxylin, dehydrated through graded ethanol, cleared in xylene, and mounted. Slides were observed with a light microscope (BX41TF, Olympus, Japan) for histological analysis. As a negative control, a section was incubated with label solution only instead of using the tunel reaction mixture. One thousand tumor cells were countered in five different sites of each tissue section at a magnification of 200ϫ. The apoptotic index (AI) was calculated as follows:
AI (%) ϭ(number of apoptotic cells/total number of cells)ϫ100
Immunohistochemical Staining After deparaffination, the tissue sections were heated at 100°C for 20 min in 10 mM sodium citrate buffer with 0.05% Tween 20 (pH 6.0) for antigen retrieval. Then the sections were incubated with anti-Bax or anti-Bcl-2 antibodies (IMGENEX) at a 1 : 200 dilution at 4°C overnight. After washed with PBS, the secondary antibody, Alexa Fluor ® 488 conjugated anti-rabbit immunoglobulin G (IgG) (Invitrogen), was added and cells were incubated at room temperature for 1 h. Then cells were counterstained with 2 mg/ml Hoechst dye for visualizing the nuclei. Finally, cells were observed with fluorescence microscopy and anti-Bax or anti-Bcl-2 positive cells were detected. The number of whole cells and positive cells were counted using image analysis software (ImageJ TM ) (NIH, Bethesda, MD, U.S.A.).
RT-PCR Tumor samples were cryopreserved in liquid nitrogen and total RNA was extracted as previously described technique. 34) Concentration of RNA was determined by the absorption at 260 nm. The primers for bcl-2, bax and b-actin were as follows: b-actin (500 bp) 5Ј-GTGGGGCGC-CCCAGGCACCA-3Ј (sense); 5Ј-CTCCTTAATGTCACG-CACGATTTC-3Ј (antisense); bcl-2 (716 bp) 5Ј-GGAAATA-TGGCGCACGCT-3Ј (sense); 5Ј-TCACTTGTGGCCCAGAT-3Ј (anti-sense); bax (508 bp) 5Ј-CCAGCTCTGAGCAGAT-CAT-3Ј (sense), 5Ј-TATCAGCCCATCTTCTTCC-3Ј (antisense). Polymerse chain reactions were performed in a 50 ml reaction volume. PCR products were electrophoresed on agarose gel, and photographed under UV light, after staining with ethidium bromide.
Data Analyses Data were analyzed by one-way ANOVA, Student's t-test or Tukey's HSD test.
RESULTS
Tumor Inhibition Rate and Morphological Changes by SAMC An inhibitory effect was observed in all therapeutic groups and the inhibition rate by SAMC at the dose of 100 mg/kg and 300 mg/kg was 31.36% and 37.78%. This showed significance at pϽ0.05 and pϽ0.01 vs. control group, respectively. The inhibition rate by the positive control, Adriamycin, at 2 mg/kg was 49.18% ( pϽ0.01) ( Table  1 ). The cells in the control group had normal morphological structures, but some cells in the therapeutic groups (SAMC, 100, 300 mg/kg) had apoptotic characteristics including chro- (Fig. 2) . The apoptosis index of control, 100 mg/kg SAMC and 300 mg/kg SAMC was 4.42Ϯ0.63, 20.74Ϯ2.50 and 30.61Ϯ2.42, respectively. These showed significance at pϽ0.01 vs. control group. The AI value of the positive control, Adriamycin (2 mg/kg) was 42.01Ϯ3.01 (pϽ0.01) ( Table 2) .
Expression of Bcl-2 and Bax Proteins Positive staining was located in the cytoplasm. The positive rate of bcl-2 protein expression in control, 100 mg/kg SAMC and 300 mg/kg SAMC was 15.20Ϯ1.67%, 10.94Ϯ1.57% and 8.24Ϯ1.07% (pϽ0.05), respectively. The positive rate of the positive control, Adriamycin (2 mg/kg), was 5.30Ϯ1.18% (pϽ0.01). The positive rate of bax protein expression in control, 100 mg/kg SAMC and 300 mg/kg SAMC was 15.30Ϯ1.90%, 23.18Ϯ 1.81%, and 25.26Ϯ3.03% (pϽ0.05), respectively, by immunohistochemical staining. The positive rate of the positive control, 2 mg/kg Adriamycin, was 26.60Ϯ1.82% (pϽ0.05). 300 mg/kg SAMC and 2 mg/kg Adriamycin showed significance at the 5% level (Table 3) .
Expression of Bcl-2 and Bax mRNA The density of bax mRNA in control, 100 mg/kg SAMC, 300 mg/kg SAMC and Adriamycin was increased progressively, and the density of bcl-2 mRNA in control, 100 mg/kg SAMC, 300 mg/kg SAMC and Adriamycin decreased progressively according to RT-PCR (Fig. 3) . 
DISCUSSION
Uncovering new anti-tumor drugs with less toxicity is an ongoing challenge in cancer research. The original source of SAMC, garlic, a plant within the Allium genus, has been used in many different cultures for disease prevention and treatment, especially for diseases of the gastrointestinal tract. Epidemiological investigations in China, Italy, and America have provided evidence that regular consumption of garlic and related garlic products decreases the risks of stomach and colon cancers. 30) Although not present in raw garlic, SAMC is a major in vivo metabolic product of the garlic compounds allicine and diallyl disulfides, 36) both of which are well known to show anticancer properties. [37] [38] [39] [40] This allylmercapto glutathione S-conjugate, SAMC, which is biotransformed from allyl sulfides and from the naturally occurring water-soluble garlic derivatives, also inhibits tumorigenesis. 30 ) SAMC also reportedly inhibits growth and induces apoptosis in SW480 and HT 29 human colon cancer cells, 32) and prostate cancer cells. 33) This anticancer activity of SAMC in vitro [30] [31] [32] [33] [34] might be related to the induction of tumor cell apoptosis.
In a previous study, we showed that SAMC was able to induce apoptosis in gastric cancer cells. The apoptosis accompanied down-regulation of the anti-apoptotic gene, bcl-2, at the same time as up-regulation of the pro-apoptotic gene, bax. In this study, we evaluated the apoptotic effect of SAMC on an implanted tumor of gastric cancer cells, and investigated the molecular mechanisms further to provide a theoretical basis for the therapeutic application of SAMC. We observed the inhibitory effect of SAMC in two therapeutic groups. Tumor cells in the control group had normal structures, but some tumor cells in the therapeutic groups had apoptotic characteristics. The apoptosis index of SAMC at doses of 100 and 300 mg/kg was increased. The protein level of bcl-2 was decreased with SAMC at doses of 100 and 300 mg/kg, but that of bax was increased. The density of bcl-2 mRNA induced by SAMC at doses of 100 and 300 mg/kg decreased progressively and the density of bax mRNA increased progressively. We hypothesized that the lowered ratio of bcl-2/bax by the altered transcriptional regulation by SAMC triggered the apoptosis of implanted tumor cells. Our results demonstrate that SAMC was able to induce the apoptosis of implanted tumors of gastric cancer cells in nude mice. SAMC may be involved in down-regulating the expression of the apoptosis-regulated gene bcl-2 and up-regulating the expression of the pro-apoptotic gene bax. These data suggest that SAMC may be used as a chemotherapeutic drug in anti-tumor chemotherapy. Vol. 34, No. 5 Fig. 3 . Expression of Bcl-2 mRNA and Bax mRNA in Apoptotic Transplanted Tumor Cells Induced by SAMC Total RNA was extracted, and of bcl-2, bax and b-actin mRNA levels were determined by RT-PCR. b-Actin was used as an internal control.
